Pharmaceuticals

GSK is one of the world’s leading vaccine developers and one of the most institutionally important companies in preventive immunization. Its vaccine business spans shingles, RSV, meningococcal disease, influenza, hepatitis, pediatric vaccines, and other infectious disease categories.

Grifols is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Global Pharmaceutical Companies 1 ranking category Overview

Gilead Sciences remains one of the most important biotechnology firms globally, with a defining position in antiviral medicine and expanding activity in oncology, cell therapy, and inflammation. The company’s institutional identity has been shaped by scientific and commercial leadership in HIV and hepatitis treatments.

Genmab is one of Europe’s leading biotechnology firms and a major global player in antibody-based therapeutics. The company is known for its antibody technology platforms, oncology focus, and partnerships with larger pharmaceutical companies.

FUJIFILM Diosynth Biotechnologies is one of the fastest-rising global biomanufacturing and CDMO providers, with major capabilities in biologics, vaccines, advanced therapies, microbial fermentation, mammalian cell culture, process development, and commercial manufacturing.

Fortrea is a major global CRO formed from the clinical development and patient access businesses formerly associated with Labcorp. The company provides clinical trial management, pharmacovigilance, regulatory affairs, data management, clinical pharmacology, and related development services for pharmaceutical and biotechnology sponsors.

Fate Therapeutics is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Cell & Gene Therapy Developers 1 ranking category Overview

Exelixis is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Biotechnology Firms 1 ranking category Overview

Evonik Health Care is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Biomanufacturing & CDMO Providers 1 ranking category Overview

Ergomed is a specialist CRO and pharmacovigilance services provider with a strong focus on rare disease, oncology, and complex clinical development programs. The company supports pharmaceutical and biotechnology sponsors through clinical trial management, regulatory support, safety services, and post-marketing pharmacovigilance.

Emmes Group is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Contract Research Organizations 1 ranking category Overview

Emergent BioSolutions is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Biomanufacturing & CDMO Providers 2 ranking categories Overview

Eli Lilly has become one of the most strategically important pharmaceutical companies in the world, driven by its leadership in diabetes and obesity medicines, alongside growing activity in oncology, immunology, neuroscience, and rare disease. The company’s rise reflects one of the most significant industry shifts of the current decade: the transformation of metabolic disease from a mature therapeutic area into one of the largest growth markets in global pharmaceuticals.

Eisai is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Global Pharmaceutical Companies 1 ranking category Overview

Editas Medicine is a gene editing company founded around CRISPR technology and has been active in ocular disease, hematology, and inherited disorders. Although the company has faced strategic shifts and competitive pressure, it remains a recognizable developer in the gene editing ecosystem.

Dyne Therapeutics is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Rare Disease & Orphan Drug Developers 1 ranking category Overview

Dynavax Technologies is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Vaccine & Immunotherapy Developers 1 ranking category Overview

Delpharm is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Biomanufacturing & CDMO Providers 1 ranking category Overview

Daiichi Sankyo is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Global Pharmaceutical Companies 1 ranking category Overview

Curia Global is an institution recognized in the 2026 Ranking News professional-ranking universe. Highest 2026 tier: Tier III Biomanufacturing & CDMO Providers 1 ranking category Overview